Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

F.D.A. Names and Shames Drug Makers to Encourage Generic Competition

NYTimes.com Thursday, 17 May 2018
In its campaign to lower drug prices, the agency posted a list of brand-name manufacturers in an effort to force them to share drug samples with their generic rivals.
0
shares
ShareTweetSavePostSend
 
Credit: Wochit - Published < > Embed
News video: FDA Names Drugmakers In Delaying Scandal

▶ FDA Names Drugmakers In Delaying Scandal 00:47

Thursday, the Food and Drug Administration named drugmakers, including Celgene Corp., Johnson & Johnson, Gilead Sciences, and Novartis AG, as companies that are potentially blocking access to samples of their drugs to delay generic competition. Generic drugmakers may not be able to develop...

You Might Like


Recent related videos from verified sources

Can Generic Drugs Replace High Branded Drugs? [Video]Can Generic Drugs Replace High Branded Drugs? 00:28

According to Business Insider, "High generic drug prices almost always stem from a lack of competition, but what drives this lack of competition can vary." That's why many companies are turning to..

Credit: Wochit - Published

U.S. Court Allows Generic Version Of Opioid Abuse Drug [Video]U.S. Court Allows Generic Version Of Opioid Abuse Drug 00:39

According to Reuters, A U.S. appeals court on Tuesday allowed generic drug company Dr. Reddy’s Laboratories to sell a copycat version of the Indivior Plc opioid treatment Suboxone Film, sending..

Credit: Wochit Business - Published


Tweets about this


Other recent news in US

President Trump grounds Nancy PELOSI military aircraft for trip to Afghanistan and BrusselsNANCY PELOSI, Chicago, Mary Oliver: Your Thursday Evening Briefing
LAQUAN MCDONALD: Chicago officers cleared of shooting cover-upEarly Addition: MICHAEL COHEN Hired Firm To Depict Him As A Sex Symbol & Rig Polls For Trump
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest